| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA631440 | A | Totla clearance of compound reported after 5 mg/kg i.v. dose in rat | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 2. | ALA629650 | A | Oral bioavailability of compound reported after 5 mg/kg i.v. dose in rat | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 3. | ALA634129 | A | Volume distribution of compound reported after 5 mg/kg i.v. dose in rat | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 4. | ALA876638 | A | Plasma half life reported after 5 mg/kg i.v. dose in rat | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 5. | ALA662658 | B | Compound was tested for inhibition human Cathepsin D | 1 | single protein format | Scientific Literature | |||
| 6. | ALA661874 | B | Compound was tested for inhibition human Cathepsin E | 1 | single protein format | Scientific Literature | |||
| 7. | ALA684614 | F | Inhibition of HIV-1 protease in a cell culture assay using HIV-1 IIIB infected H9 cells. | Human immunodeficiency virus 1 | 32 | cell-based format | Scientific Literature | ||
| 8. | ALA685390 | F | Inhibition of HIV-1 protease in a cell culture assay using HIV-1 IIIB infected H9 cells. | Human immunodeficiency virus 1 | 32 | cell-based format | Scientific Literature | ||
| 9. | ALA756511 | B | Inhibition of human pepsin | Homo sapiens | 1 | single protein format | Scientific Literature | ||
| 10. | ALA763874 | B | Compound was tested for inhibition of HIV protease triple mutant (Q7K/L33I/L63I) | 2 | single protein format | Scientific Literature | |||
| 11. | ALA763398 | B | Inhibitory activity against HIV-1 protease in tandem assay. | Human immunodeficiency virus 1 | 36 | single protein format | Scientific Literature | ||
| 12. | ALA772928 | B | Compound was tested for inhibition of HIV protease | 1 | single protein format | Scientific Literature | |||
| 13. | ALA769361 | B | Tested for inhibition of HIV protease | 14 | single protein format | Scientific Literature | |||
| 14. | ALA760745 | B | Compound was tested for inhibition of HIV protease in AZT Resistant HIV-1 clinical isolates in primary PBMC | 1 | single protein format | Scientific Literature | |||
| 15. | ALA832539 | B | Initial effective dose against protease of human immunodeficiency virus type 1 | Human immunodeficiency virus 1 | 1 | single protein format | Scientific Literature | ||
| 16. | ALA832562 | B | Effective dose against protease of human immunodeficiency virus type 1 | Human immunodeficiency virus 1 | 1 | single protein format | Scientific Literature | ||
| 17. | ALA833855 | F | Protease inhibitory activity against wild type HIV-1 IIIB was determined | Human immunodeficiency virus 1 | 26 | organism-based format | Scientific Literature | ||
| 18. | ALA833117 | F | Protease inhibitory activity against HIV-1 r13025 mutant strain was determined | Human immunodeficiency virus 1 | 26 | organism-based format | Scientific Literature | ||
| 19. | ALA833119 | F | Protease inhibitory activity against HIV-1 r13363 mutant strain was determined | Human immunodeficiency virus 1 | 26 | organism-based format | Scientific Literature | ||
| 20. | ALA833275 | F | Protease inhibitory activity against HIV-1 GSS004421 mutant strain was determined | Human immunodeficiency virus 1 | 26 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!